Clinical management of amyloid cardiomyopathy.

Kim, Morris M; Kolseth, Clinton M; Carlson, Dayna; Masri, Ahmad

Kim, Morris M; Kolseth, Clinton M; Carlson, Dayna; Masri, Ahmad.

Affiliation

Kim MM; Center for Amyloidosis, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
Kolseth CM; Center for Amyloidosis, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
Carlson D; Center for Amyloidosis, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
Masri A; Center for Amyloidosis, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA. masria@ohsu.edu.

Heart Fail Rev ; 27(5): 1549-1557, 2022 09.

Article in En | MEDLINE | ID: mdl-34471997

Subject(s)

Amyloidosis; Cardiomyopathies; Heart Failure; Amyloidosis/complications; Amyloidosis/therapy; Arrhythmias, Cardiac/therapy; Cardiomyopathies/complications; Cardiomyopathies/therapy; Heart Failure/complications; Heart Failure/therapy; Humans

Key words

Amyloidosis; Atrial fibrillation; Heart failure; Orthostatic hypotension; Restrictive cardiomyopathy; Sudden cardiac death

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure / Amyloidosis / Cardiomyopathies Type of study: Guideline Limits: Humans Language: En Journal: Heart Fail Rev Journal subject: CARDIOLOGIA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google